ResMed
361 hedge funds and large institutions have $5.53B invested in ResMed in 2016 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 172 increasing their positions, 100 reducing their positions, and 46 closing their positions.
72% more repeat investments, than reductions
Existing positions increased: 172 | Existing positions reduced: 100
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
30% more call options, than puts
Call options by funds: $18.4M | Put options by funds: $14.2M
16% more capital invested
Capital invested by funds: $4.77B → $5.53B (+$762M)
2.62% more ownership
Funds ownership: 59.7% → 62.32% (+2.6%)
3% less funds holding
Funds holding: 374 → 361 (-13)
20% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 46
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$65.7M |
| 2 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
+$61.7M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$55.8M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$42.4M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$41.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
American Capital Management
New York
|
-$40.1M |
| 2 |
Renaissance Technologies
New York
|
-$29.1M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$28.6M |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$23.1M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$19.2M |
RMD Hedge Fund Activity: Q2 2016 in Review
361 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q2 2016, worth a combined $5.53B — up 16% from $4.77B a quarter earlier.
Sellers outnumbered buyers: 46 funds closed out of RMD and 37 opened new positions — a net loss of 9 holders — while 100 trimmed existing stakes and 172 added.
The largest buyer was Vanguard Group, adding an estimated $65.7M. The largest seller was American Capital Management, exiting entirely with an estimated $40.1M sold.
- 361 institutional investors held ResMed (RMD) as of Q2 2016, down from 374 in Q1 2016.
- Funds reported $5.53B of ResMed stock for Q2 2016, up 16% quarter-over-quarter.
- 37 funds opened new ResMed positions in Q2 2016 and 46 closed out, a net change of -9 holders.
- The largest ResMed buyer in Q2 2016 was Vanguard Group, an estimated $65.7M added.
- The largest ResMed seller in Q2 2016 was American Capital Management, an estimated $40.1M sold.
Based on aggregated 13F filings for Q2 2016.